Prolactin levels and antinuclear antibody profiles in women tested for connective tissue disease

Lupus

Volumn 5, Issue 1, 1996, Pages 30-37

  Allen, S H ^a   Sharp, G C ^a,b   Wang, G ^b   Conley, C ^b   Takeda, Y ^c   Conroy, S E ^d   Walker, S E ^a,b,e  

^a University of Missouri   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoantibodies; Prolactin; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DOUBLE STRANDED DNA; PROLACTIN;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOTHYROIDISM; IMMUNOBLOTTING; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030058737     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120339600500107     Document Type: Article

References (26)

1. Berczi I. The immunology of prolactin. Semin Reprod Endocrinol 1992; 10: 196-219.
2. Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991; 18: 349-53.
3. Jara LJ, Gomez-Sanchez C, Silviera LH, Martinez-Osuna P, Vasey FB, Espinoza LR. Hyperprolactinemia in systemic lupus erythematosus: association with disease activity. Am J Med Sci 1992; 303: 222-6.
4. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: Possible stimulation of an autoimmune disease. J Rheumatol 1994; 21: 843-50.
5. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982; 25: 1271-7.
6. Sharp GC, Irvin WS, May CM, et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases. New Engl J Med 1976; 295: 1149-54.
7. Petterson I, Wang G, Smith EI, et al. The use of immunoblotting and immunoprecipitation of (U) small nuclear ribonucleoproteins in the analysis of sera of patients with mixed connective tissue disease and systemic lupus erythematosus. Arthritis Rheum 1986; 29: 986-96.
8. Takeda Y, Wang GS, Wang RJ, et al. Enzyme-linked immunosorbent assay using isolated (U) small nuclear ribonucleoprotein polypeptides as antigens to investigate the clinical significance of autoantibodies to these polypeptides. Clin Immunol Immunopathol 1989; 50: 213-30.
9. Craft J, Mimori T, Olsen TL, Hardin JA. The U2 small nuclear ribonucleoprotein particle as an autoantigen. Analysis with sera from patients with overlap syndromes. J Clin Invest 1988; 81: 1716-24.
10. Conroy SE, Faulds GB, Williams W, Latchman DS, Isenberg DA. Detection of autoantibodies to the 90kD heat shock protein in systemic lupus erythematosus and other autoimmune diseases. Brit J Rheumatol 1994; 33: 923-926.
11. Takeda Y, Nyman U, Winkler A, et al. Antigenic domains on the U1 small nuclear ribonucleoprotein-associated 70K polypeptide: A comparison of regions selectively recognized by human and mouse autoantibodies and by monoclonal antibodies. Clin Immunol Immunopathol 1991; 61: 55-68.
12. Pettersson I, Hinterberger M, Mimori T, Gottlieb E, Steitz JA. The structure of mammalian small nuclear ribonucleoproteins: Identification of multiple protein components reactive with anti-(U1) ribonucleoprotein and anti-Sm autoantibodies. J Biol Chem 1984; 259: 5907-14.
13. Miyai K, Ichihar K, Kondo K, Mori S. Asymptomatic hyperprolactinemta and prolactinoma in the general population - Mass screening by paired assays of serum prolactin. Clin Endocrinol 1986; 25: 549-54
14. Sawin CT, Carlson HE, Geller, A, Castelli WP, Bacharach P. Serum prolactin and aging: basal values and changes with estrogen use and hypothyroidism. J Gerontol 1989; 44: M131-5.
15. Tolis G. Prolactin: physiology and pathology. In: Krieger DT, Hughes JC (Eds) Neuroendocrinology. Sinauer Associates, Inc: Sunderland, MA, 1980, 321-8.
16. Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metab Clin 1992; 21: 877-901.
17. Noel GL, Suh HK, Stone JG, Frantz AG. Human prolactin and growth hormone release during surgery and other conditions of stress. J Clin Endocrinol 1974; 3: 427-35.
18. Carlson HE, Wasser HL, Levin SR, Wilkins JN. Prolactin stimulation by meals is related to protein content. J Clin Endocrinol Metab 1983; 57: 334-8.
19. Miller FW, Moore GF, Weintraub BD, Steinberg AD. Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum 1987; 30: 1124-31.
20. Margaro M, Zoli A, Altomonte L, et al. The association of silent thyroiditis with active systemic lupus erythematosus. Clin Exp Immunol 1992; 10: 67-70.
21. Weetman AP, Walport MJ. The association of autoimmune thyroiditis with systemic lupus erythematosus. Brit J Rheumatol 1987; 26 359-61.
22. Ferrari C, Boghen M, Paracchi A, et al. Thyroid autoimmunity in hyperprolactinemic disorders. Acta Endocrinol 1983; 104: 35-41.
23. Alexander EL, Hirsch TJ, Arnett FC, Provost TT, Stevens MB. Ro (SSA) and La (SSB/La) antibodies in the clinical spectrum of Sjögren's syndrome. J Rheumatol 1982; 9: 239-46.
24. Gutierrez MA, Anaya J-M, Scopelitis E, Citera G, Silveira LH, Espinoza LR. Hyperprolactinemia in primary Sjögren's syndrome. Ann Rheum Dis 1994; 53: 425.
25. Hardin JA, Thomas JO. Antibodies to histones in systemic lupus erythematosus: Localization of prominent autoantigens on histones H1 and H2B. Proc Natl Acad Sci USA 1983; 80: 7410-4.
26. Francoeur A, Peebles CL, Heckman KJ, Lee JC, Tan EM. Identification of ribosomal protein antigens. J Immunol 1985; 135: 2378-83.